Cargando…

Platelets and the Endothelium: Active Participants in Severe COVID-19 Infection

[Figure: see text]

Detalles Bibliográficos
Autores principales:	Parker, William A.E., Storey, Robert F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Editorial Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987542/ https://www.ncbi.nlm.nih.gov/pubmed/33778209 http://dx.doi.org/10.1016/j.jacbts.2021.01.009

Ejemplares similares

Transcriptional Profiling Identifies Mechanisms Associated With Platelet Activation in HIV Infection
por: Funderburg, Nicholas
Publicado: (2018)

Participant stress in the COVID-19 era and beyond
por: Goldfarb, Elizabeth V.
Publicado: (2020)

Managing secondary fungal infections in severe COVID-19: how to move forward?
por: Verweij, Paul E, et al.
Publicado: (2022)

Azithromycin for severe COVID-19
por: Oldenburg, Catherine E, et al.
Publicado: (2020)

Will helminth co-infection modulate COVID-19 severity in endemic regions?
por: Bradbury, Richard S., et al.
Publicado: (2020)

Severe breakthrough COVID-19 infections in Scotland—implications for immunisation programmes
por: Leshem, Eyal, et al.
Publicado: (2021)

Viral infection at the endothelium
por: Goodrum, Felicia, et al.
Publicado: (2015)

An immunological autobiography: my year as a COVID-19 vaccine trial participant
por: Kedl, Ross M.
Publicado: (2022)

Sulfasalazine: a risk factor for severe COVID-19?
por: Konig, Maximilian F, et al.
Publicado: (2022)

Baricitinib for patients with severe COVID-19—time to change the standard of care?
por: Supady, Alexander, et al.
Publicado: (2022)

Mean platelet size: Looking at the chicken or the egg?
por: Lancé, Marcus D.
Publicado: (2015)

Circulating levels of soluble Dipeptidylpeptidase-4 are reduced in human subjects hospitalized for severe COVID-19 infections
por: Schlicht, Kristina, et al.
Publicado: (2020)

Platelet Function Testing and Clinical Outcomes: Connecting the Dots
por: Schneider, David J.
Publicado: (2019)

COVID-19 severity and obesity: are MAIT cells a factor?
por: McCarthy, Cormac, et al.
Publicado: (2021)

Observational research on severe COVID-19 in diabetes
por: Stehouwer, Coen D A
Publicado: (2021)

Mounting evidence of impaired viral control in severe COVID-19
por: Bermejo-Martin, Jesus F, et al.
Publicado: (2021)

Important lessons for infection control in radiology departments during the COVID-19 pandemic
por: Devaraj, Anand
Publicado: (2020)

Is aberrant CD8+ T cell activation by hypertension associated with cardiac injury in severe cases of COVID-19?
por: Zhang, Chao, et al.
Publicado: (2020)

Treatment for severe acute respiratory distress syndrome from COVID-19
por: Matthay, Michael A, et al.
Publicado: (2020)

Clinical course and mortality risk of severe COVID-19
por: Weiss, Paul, et al.
Publicado: (2020)

Epidemiology of severe COVID-19 from South Africa
por: Madhi, Shabir A, et al.
Publicado: (2021)

Are women with asthma at increased risk for severe COVID-19?
por: Fernando, Mario, et al.
Publicado: (2021)

The effects of antihypertensive medications on severity and outcomes of COVID19
por: Agirbasli, Mehmet
Publicado: (2022)

Severe COVID-19 pneumonitis and timing of birth in women
por: Calvert, Clara, et al.
Publicado: (2023)

Severe mental illness and European COVID-19 vaccination strategies
por: De Picker, Livia J, et al.
Publicado: (2021)

Epicardial fat as a predictor of COVID-19 disease severity: Just a surrogate for obesity or a true independent predictor?
por: Strong, Christopher
Publicado: (2022)

Who, what, and when—effective therapy for severe COVID-19
por: Kelmenson, Daniel A, et al.
Publicado: (2022)

Severe COVID-19 and preexisting hypertension: a matter of age?
por: Yamazaki, Osamu, et al.
Publicado: (2022)

Prognostic value of mean platelet volume in patients after acute coronary syndrome
por: Jakl, Martin, et al.
Publicado: (2015)

Worldwide physical activity trends since COVID-19 onset
por: Tison, Geoffrey H, et al.
Publicado: (2022)

Platelet-Derived Growth Factors: A New Therapeutic Opportunity for Treating Cardiac Fibrosis?
por: Mouton, Alan J.
Publicado: (2023)

Severe COVID-19 in the young and healthy: monogenic inborn errors of immunity?
por: Zhang, Shen-Ying, et al.
Publicado: (2020)

A role for interleukin-1 receptor antagonism in severe COVID-19?
por: Tattersall, Rachel S, et al.
Publicado: (2021)

Stimulating severe COVID-19: the potential role of GM-CSF antagonism
por: Leavis, Helen L, et al.
Publicado: (2022)

Management of pregnant women infected with COVID-19
por: Luo, Yongwen, et al.
Publicado: (2020)

Blood lipids after COVID-19 infection
por: Durrington, Paul
Publicado: (2023)

COVID-19 infection, reinfection, and the transition to endemicity
por: Cohen, Cheryl, et al.
Publicado: (2023)

New insights into the association between body-mass index and severe COVID-19
por: Bhaskaran, Krishnan
Publicado: (2021)

Rise in diabetic ketoacidosis during the COVID-19 pandemic: several questions remain
por: Misra, Shivani
Publicado: (2022)

COVID-19 vaccination is effective at preventing severe illness and complications during pregnancy
por: Ellington, Sascha, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_n7dbbhkegkslhnkoq21p646j9p